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Abstract Sam68 is an RNA binding protein that is tyrosine-
phosphorylated by Src during mitosis and has been postulated to
have a role in cell cycle control by modulating RNA metabo-
lism. To elucidate the function of this protein, we isolated a
Sam68-de¢cient DT40 cell line by gene disruption. The
Sam68-de¢cient cells exhibited markedly decreased growth
and the growth retardation was due to elongation of the G2-
M phase, however, the kinase activity associated with Cdc2
remained unaltered. Our results indicate that Sam68 may play
a critical role in G2-M progression in a manner independent of
the control of Cyclin/Cdc2 kinase activity. , 2002 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Sam68 belongs to a family of RNA binding proteins called
the STAR (signal transduction and activation of RNA metab-
olism) family [1], whose members retain a stretch of a con-
served KH (hnRNP K homology) domain embedded in a
larger GSG (GRP33-Sam68-GLD-1) homology region [2].
These domains have been shown to be responsible for RNA
binding [3,4] and dimer formation [5,6]. There is considerable
genetic evidence, obtained for various species, supporting a
physiological role of the KH domain [6^8].
Sam68 was originally identi¢ed as a M phase-speci¢c target
of c-Src [9,10], and shown to interact with various cellular
molecules such as Src family protein kinases [11^13], Grb2
[12,13], PLCQ1 [12^14], PI3K [13,15], Nck [16], Jak3 [13]
and STAT3 [17]. Furthermore, since tyrosine phosphorylation
of Sam68 in vitro decreases its RNA binding properties [18], a
functional role of Sam68 in linking signal transduction to
RNA metabolism is indicated.
It has been demonstrated that over-expression of a Sam68
isoform with the deletion of its KH domain by alternative
splicing resulted in the suppression of cell growth [19]. In
addition, the reduction of Sam68 expression by means of a
retroviral-based antisense RNA strategy resulted in neoplastic
transformation of NIH3T3 cells [20]. These results strongly
indicate a functional role of Sam68 in the control of cell
growth.
On the other hand, Sam68 was recently shown to function
as a cellular homologue of the HIV-1 Rev protein by trans-
porting unspliced viral RNA into the cytoplasm [21]. How-
ever, the mechanism of nuclear export of viral RNA by
Sam68 as well as the biological role, if any, of Sam68 in the
nuclear export of cellular RNA remained to be elucidated.
We report here the isolation of Sam68-de¢cient cells from
the chicken DT40 cell line by the gene disruption procedure.
The growth rate of the Sam68-de¢cient cells was signi¢cantly
reduced compared with that of the wild-type and the growth
retardation was mainly due to elongation of the G2-M phase,
although the Cdc2 kinase activity, the key for G2-M progres-
sion, was not a¡ected by the loss of Sam68 expression. These
results constitute evidence of the involvement of Sam68 in G2-
M progression through a mechanism not involving modula-
tion of Cdc2 kinase activity.
2. Materials and methods
2.1. Isolation of cDNA and genomic DNA of chicken Sam68
A 0.7 kb chicken Sam68 cDNA fragment was ampli¢ed from DT40
total RNA by reverse transcription polymerase chain reaction (RT-
pCR) using synthetic oligonucleotides corresponding to the KH re-
gion of human Sam68 cDNA (sense primer, 5P-GGATTTATTTTCT-
CATAAGAACATG-3P, antisense primer, 5P-TGGATCTGCATGTC-
TTCATTGAAGTC-3P) and used as a probe for screening of a V ZAP
DT40 cDNA library. A plasmid clone with a 2.4 kb cDNA fragment
was obtained from hybridized bacteria by means of super-infection
with helper M13 phage. Using synthetic oligonucleotides correspond-
ing to the 5P- and 3P-non-coding sequences (5P-GTCCTTCCGGCCC-
TCACTTCC-3P and 5P-CCTGTTGCTTTGCCCACACCCAGACA-
AGTAA-3P, respectively), a 9.2 kb genomic DNA fragment was
PCR-ampli¢ed and sub-cloned into the pGEM-T vector (Stratagene,
San Diego, CA, USA).
2.2. Cells and gene disruption
DT40 cells and mutant clones of them were cultured in RPMI 1640
medium supplemented with 10% fetal calf serum, 1% chicken serum
(Sigma), and 50 mM 2-mercaptoethanol at 37‡C under 5% CO2.
0014-5793 / 02 / $22.00 K 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 2 ) 0 3 1 0 3 - 4
*Corresponding author. Fax: (81)-6-6993 1668.
E-mail address: fujisawa@takii.kmu.ac.jp (J.-i. Fujisawa).
1 The chicken Sam68 cDNA nucleotide sequence has been submitted
to GenBank database under accession number AY057837.
Abbreviations: Sam68, src-associated substrate in mitosis of 68 kDa;
STAR, signal transduction and activation of RNA metabolism;
hnRNP, heterogeneous nuclear ribonucleoprotein; KH, K homology;
GLD-1, germline defective-1; GSG, GRP33-Sam68-GLD-1; PCR,
polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis
FEBS 26361 2-8-02
FEBS 26361 FEBS Letters 525 (2002) 145^150
Targeting vectors, CSG-bsr and CSG-hisD, were constructed by
replacing the genomic fragment containing exons encoding amino
acid residues 179^321 of chicken Sam68 with a bsr or hisD expression
cassette. 25 Wg of CSG-bsr was linearized by SalI restriction cleavage
and then transfected into DT40 cells by electroporation (550 V,
25 WFD). After selection of clones in the presence of blasticidin S
(Funakoshi, Tokyo, Japan) at a concentration of 50 Wg/ml, genomic
DNAs were prepared from drug-resistant cell clones and screened by
Southern blot analysis. 25 Wg of linearized CSG-hisD DNA was
further transfected into the clone with deletion of the Sam68 gene
on the haploid genome, and selected with both blasticidin S and
L-hisdinol (Sigma) at concentrations of 50 Wg/ml and 1 mg/ml, respec-
tively.
2.3. Transduction of chicken Sam68 cDNA
An amphotropic retrovirus vector expressing chicken Sam68 cDNA
was isolated from a culture supernatant of PT67 packaging cell line
that had been infected with an ecotropic retrovirus produced by
BOSC23 cells transfected with a vector plasmid, pRchicken-Sam68-
puro. DT40 cells with gene disruption were infected with the ampho-
tropic retrovirus and then selected with puromycin at a concentration
of 0.5 Wg/ml in the culture medium.
2.4. Southern blot analyses
Genomic DNA was prepared from wild-type and Sam68-de¢cient
cells using DNAZOL1 reagent (Gibco-BRL). 10 Wg of DNA was di-
gested with EcoRI, separated in a 0.8% agarose gel, transferred to a
Hybond1-N+ transfer membrane (Amersham), and then probed with
a 32P-labeled BamHI^BglII genomic fragment of 1 kb long.
2.5. Protein analysis
Cells were lysed in solubilization bu¡er (1% Nonidet P40, 150 mM
Tris^HCl, pH 7.4, 50 U/ml Trasylol (Bayer, Leverkusen, Germany),
and 1 mM Na3VO4 (Sigma)) at 4‡C. The lysates were cleared by
centrifugation, and then 10 Wg aliquots of lysates were separated by
7.5% SDS^PAGE, electro-blotted onto an Immobilon1 transfer
membrane (Millipore), and then probed with rabbit antiserum against
human Sam68 (Santa-Cruz, San Diego, CA, USA). Chemilumines-
cence obtained with horseradish peroxidase-conjugated protein A
(ECL System; Amersham) was used for protein detection.
Fig. 1. Disruption of the Sam68 gene in chicken DT40 cells. A: Structures of the chicken Sam68 gene (upper panel) and targeting vectors (mid-
dle and lower panels). Each exon contains functional motifs such as the GSG motif, KH motif, proline-rich motif, tyrosine-rich motif, and nu-
clear localization signal (NLS). B: Southern blot analysis. Genomic DNAs from wild-type cells (lane 2), mutant cells with recombination in a
haploid allele (#36) (lane 3), and knocked-out clones #8, #10, #11, #13 and #15 (lanes 4^8) were digested with EcoRI, and probed with a 32P-
labeled 1 kb genomic fragment encompassing the 5P-GSG and KH exons. C: Protein analysis of chicken Sam68. Proteins prepared from wild-
type and mutant cells were subjected to a 7.5% SDS^PAGE and then analyzed by Western blotting with an anti-Sam68 antibody.
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2.6. Cell cycle analysis by £ow cytometry
5U105 cells were ¢xed with 50% methanol at 4‡C overnight,
washed with phosphate-bu¡ered saline, and then suspended in
Na2HPO4^citrate bu¡er at room temperature. After RNase treatment
at 37‡C for 30 min, the cells were stained with a propidium iodide
solution for 30 min on ice. Cell samples were ¢ltered into 12U75 mm
tubes and subjected to analysis with a FACScan (Becton Dickinson),
and then cell cycle analysis was performed with the ModFit program
(Verity Software House).
2.7. Histone H1 kinase assay
25U106 cells were collected and protein extracts were prepared as
previously described. 25 Wg of a cell lysate was incubated with 0.2 Wg
of anti-Cdc2 monoclonal antibody (Santa Cruz) on ice for 2 h, fol-
lowed by incubation with protein A-Sepharose for 1 h at 4‡C. The
immunoprecipitate was washed twice with lysis bu¡er and once with
assay bu¡er (50 mM Tris^HCl, pH 7.4, 10 mM MgCl2 and 1 mM
dithiothreitol), and then suspended in 10 Wl of assay bu¡er. The re-
action was started by the addition of ATP at the ¢nal concentration
of 1 WM with 5 WCi [Q32P]ATP and 0.5 mg/ml H1 histone (Alexis0
Biochemicals), and continued at 30‡C for 5 min. The samples were
analyzed on a 12% SDS^polyacrylamide gel and exposed to X-ray
¢lm for 12 h.
3. Results
3.1. Targeted disruption of the chicken Sam68 gene
In order to disrupt the Sam68 gene in the chicken DT40 B
cell line by homologous recombination, we ¢rst isolated chick-
en Sam68 cDNA as described in Section 2. The overall se-
quence homology at the amino acid and nucleotide levels was
75% and 78%, respectively, between human Sam68 and the
isolated cDNA. Since a stretch of a 138 amino acid sequence
including the KH domain was identical and the putative func-
tional domains, such as the proline-rich domain, tyrosine-rich
domain, and nuclear localization signal, were almost
completely conserved, we concluded that this gene was the
chicken orthologue of Sam68 (GenBank accession number
AY057837).
Then, we PCR-ampli¢ed a 9.2 kb genomic fragment from
DT40 genomic DNA using primers corresponding to the se-
quences of the 5P- and 3P-non-coding regions in the cDNA
and constructed targeting vectors by replacing a 4.1 kb ge-
nomic fragment covering the 3P half of the KH exon and a
part of the 3P GSG domain with an expression cassette of a
drug resistance gene, bsr and his (Fig. 1A). After sequential
transfection of targeting vectors into DT40 cells, cell clones
with homologous recombination in both alleles were selected
by cell culture in the presence of selection drugs, blasticidin
and histidionol, and further screened by Southern blot anal-
ysis of genomic DNA. EcoRI digestion of genomic DNA
prepared from drug-resistant cell clones gave two bands of
14 kb and 15 kb (cell clones #8, #10, #11, #13 and #15, lanes
4^8, respectively, in Fig. 1B) instead of a 23 kb band, which
was observed for wild-type cells (lane 2, Fig. 1B) and a singly
knocked-out clone, #36 (lane 3, Fig. 1B).
Protein blot analysis with antiserum against human Sam68
demonstrated that ¢ve clones, #8, #10, #11, #13 and #15,
lacked expression of the Sam68 protein (lanes 3^7, Fig. 1C).
Northern analysis with a probe for the KH domain also con-
¢rmed the loss of a 3 kb mRNA in knocked-out cells, which
was observed for the wild-type and a mutant clone with re-
combination in a single allele (data not shown).
3.2. Growth retardation of Sam68-de¢cient DT40 cells
When the growth rates of Sam68-de¢cient and wild-type
DT40 cells were monitored, the Sam68-de¢cient cells were
found to grow signi¢cantly more slowly than the wild-type
and the doubling times of two independent Sam68-de¢cient
clones (#8 and #15) were 13.7 and 13.2 h, respectively, where-
as the parent DT40 cells multiplied once in 9.9 h at 37‡C
(Fig. 2).
To con¢rm that the retarded growth of knocked-out cells
was due to the loss of Sam68 expression, chicken Sam68
cDNA was introduced into one of the knocked-out cell clone,
#15, by means of a retrovirus vector. Although the amount of
Sam68 protein expressed from the retrovirus vector was less
than half of that in the case of the wild-type (lane 8, Fig. 1C),
the growth rate of cDNA-transduced cells recovered substan-
tially and the doubling time was reduced to 10.7 h (Fig. 2).
Therefore, we concluded that the abolition of Sam68 expres-
sion led to retardation of cell growth.
3.3. The G2-M phase was elongated in Sam68-de¢cient cells
To clarify the points in the cell cycle that were a¡ected by
deletion of the Sam68 gene, £ow-cytometric analysis was car-
ried out. The cell cycle pattern of each cell clone demonstrated
that the ratio of the G2-M phase to G1-S phase was signi¢-
cantly increased in Sam68 knocked-out cells (Fig. 3A). The
lengths of the phases of the cell cycle were determined by
multiplying the doubling time (Fig. 2, inset) by the percentage
of each phase, and the results indicated that the G2-M phase
was speci¢cally a¡ected in knocked-out cells (Fig. 3B). While
the G0-G1 and S phases of two knocked-out cell clones re-
mained substantially unchanged, the G2-M phase in mutant
clones was elongated more than two-fold. Again, re-expres-
sion of chicken Sam68 in the knocked-out cells shortened the
length of the G2-M phase, indicating an e¡ect of Sam68 gene
disruption on G2-M progression.
3.4. Cdc2 kinase activity in Sam68-de¢cient cells
It has been well demonstrated that the kinase activity of the
cyclin B^Cdc2 complex drives progression of the G2-M phase
in the cell cycle. Therefore, the Cdc2 kinase activity in Sam68
Fig. 2. Growth curves for chicken Sam68-de¢cient cells. 104 cells/
well of the wild-type (F), two lines of Sam68-de¢cient cells, #8 (O)
and #15 (a), and the Sam68 cDNA-transduced #15 mutant cells
(b) were plated in a six well culture dish, and the cell number was
determined in triplicate every 12 h. Data represent the meanU
S.E.M. The doubling time shown in the inset is the average of three
independent experiments.
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mutant cells was examined in comparison with that in wild-
type DT40 cells. Cdc2 kinase was immunoprecipitated in cell
extracts prepared from wild-type and mutant cells with an
anti-Cdc2 antibody, and the immune complexes were incuba-
ted with [Q-32P]ATP and histone H1 as substrates. As shown
in Fig. 4, similar kinase activities, as indicated by the 32P
intensity with histone H1, were demonstrated in Sam68-de¢-
cient cells. These results strongly indicated that the retarda-
tion of G2-M progression observed in Sam68-de¢cient DT40
cell was not due to a change in Cdc2 kinase activity.
Fig. 3. Flow-cytometric analysis of Sam68-de¢cient DT40 cells. A: Sam68 knocked-out cells (b, #8; c, #15) showed an increased G2-M phase
compared to wild-type (a) and cDNA-transformed (d) cells. B: Phase lengths of the cell cycle in wild-type, Sam68 knocked-out #8 and #15
and cDNA-transformed knocked-out #15 cells.
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4. Discussion
We demonstrated here that deletion of the Sam68 gene in
chicken DT40 cells resulted in growth retardation due to elon-
gation of the G2-M phase in the cell cycle. Since exogenous
expression of Sam68 cDNA in the knocked-out cells could
reverse the growth defect, it was strongly suggested that
Sam68 is involved in G2-M progression in the cell cycle.
On the other hand, Barlet et al. [19] documented that the
expression of a splicing variant of Sam68, in which part of
KH is deleted, inhibited serum-stimulated progression to the
S phase of the cell cycle. The reason for the discrepancy be-
tween the two experiments is uncertain. However, the mutant
Sam68 protein lacking the RNA binding domain could interact
with signaling molecules in a dominant-negative fashion, lead-
ing to inhibition of signal transduction irrespective of the con-
trol of RNA metabolism. Therefore, over-expression of the
variant Sam68 molecule could result in a di¡erent consequence
in cell growth control from the depletion of the natural form of
Sam68. In this respect, it should be noted that Sam68 is tyro-
sine-phosphorylated and Src-associated only in mitosis, and
that the RNA binding property of Sam68 is impaired when
it is phosphorylated [18]. The mitotic phosphorylation of
Sam68 at threonine residues by Cdc2 has also been demon-
strated [22]. Thus, a major part of the Sam68 function could be
closely linked to M phase progression. In fact, the treatment of
Src-transformed ¢broblasts with a Src-tyrosine kinase inhibi-
tor, radicicol, blocked the mitosis-speci¢c phosphorylation of
Sam68 and retarded the exit of cells from mitosis [23].
In murine NIH3T3 ¢broblasts, homozygous functional in-
activation of Sam68 by means of a retrovirus-based antisense
RNA strategy has been shown to lead to neoplastic transfor-
mation [20]. This indicated the possible role of Sam68 as a
tumor suppressor, as indicated in the case of another STAR
protein, GLD-1, in Caenorhabditis elegans [24]. However, as
re-expression of Sam68 did not uniformly reverse phenotypic
abnormalities, the authors suggested that some neoplastic pro-
gression had occurred during antisense-induced Sam68 de¢-
ciency through some indirect mechanism. In this context, it
would be interesting to postulate that the alteration of G2-M
progression observed in Sam68-de¢cient DT40 cells may re-
£ect some defect(s) in the G2-M checkpoint, which could lead
to neoplastic transformation.
Although an activity of Sam68 in the enhancement of Rev-
mediated nuclear export of unspliced HIV-1 mRNA has been
demonstrated [21], the function was inhibited by olomoucine,
an inhibitor of Cdc2 kinase [25]. The result also strongly in-
dicates the close association of Sam68 function with mitotic
control.
Wang et al. [26] have reported a defect in cell growth due to
the loss of an RNA binding protein, HuR, in a colorectal
carcinoma cell line. Suppression of HuR expression resulted
in instability of the mRNAs encoding cyclin A and cyclin B1
and thus the reduction of cyclin/Cdc2 kinase activity was at-
tributed to the blockade of cell cycle progression mostly in the
S and G2-M phases. In the case of Sam68-de¢cient cells,
however, the Cdc2 kinase activity did not change although
substantial retardation of cell growth was observed in the
G2-M phase. Therefore some machinery, yet unknown, other
than the cyclin B/Cdc2 kinase complex should go out of con-
trol with the loss of Sam68 expression in DT40 cells.
In this sense, it is of note that Hill et al. [27] have reported
the co-localization of Sam68 with L-actin mRNA in the pe-
ripheral regions on cell motility in response to serum stimu-
lation. Thus, the metabolism of mRNAs for proteins involved
in cytokinesis or cell motility such as L-actin could be modu-
lated by Sam68 during G2-M progression in the cell cycle.
To understand the mechanism(s) responsible for the G2-M
retardation, RNA species whose functions are modulated by
Sam68 should be found, but so far little is known as to the
target RNA molecules for Sam68. We are currently identify-
ing target mRNA species for Sam68. Combined with the in-
formation on the target molecules, the Sam68-de¢cient cell
line obtained in this report should provide a novel reagent
that should prove useful for further studies elucidating the
possible mechanism of cell growth control though the RNA
metabolism.
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